Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer

Author： Limacher Jean-Marc   Spring-Giusti Clémentine   Bellon Nadine   Ancian Philippe   Rooke Ronald   Bonnefoy Jean-Yves  

Publisher： Informa Healthcare

ISSN： 1476-0584

Source： Expert Review of Vaccines, Vol.12, Iss.3, 2013-03, pp. : 263-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 3, 2015-06 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Small RNAs and Non-Small Cell Lung Cancer

By  

Current Molecular Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 339-349

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 405-410

Spandidos Publications

Access to resources Recommend Favorite

Pemetrexed versus vinorelbine treatment of advanced nonsquamous non-small cell lung cancer in elderly patients

By Chen  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 553-557

Spandidos Publications

Access to resources Recommend Favorite

Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite